Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-09-15DNA144HENRY CHRISTIAN O plan to sell securities of Ginkgo Bioworks Holdings, Inc. under Form 144MEDIUM
HENRY CHRISTIAN O filed Form 144 to notify SEC of plan to sell 5000 units of Ginkgo Bioworks Holdings, Inc. securities around 2026-09-15, with aggregate market value of $35,405.99. The total outstanding units is 55383808.0. The amount planned to be sold represents 0.01% of total outstanding units; ...
Small CapBiotechnology
2026-09-15Ginkgo Bioworks Holdings, Inc.144HENRY CHRISTIAN O plan to sell securities of Ginkgo Bioworks Holdings, Inc. under Form 144DuplicateMEDIUM
HENRY CHRISTIAN O filed Form 144 to notify SEC of plan to sell 5000 units of Ginkgo Bioworks Holdings, Inc. securities around 2026-09-15, with aggregate market value of $35,405.99. The total outstanding units is 55383808.0. The amount planned to be sold represents 0.01% of total outstanding units; ...
Small CapBiotechnology
2026-09-15INBX144MANHARD KIMBERLY plan to sell securities of Inhibrx Biosciences, Inc. under Form 144MEDIUM
MANHARD KIMBERLY filed Form 144 to notify SEC of plan to sell 500 units of Inhibrx Biosciences, Inc. securities around 2026-09-15, with aggregate market value of $52,525.00. The total outstanding units is 14717660.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past ...
Small CapBiotechnology